Explore how Generative AI is reshaping molecular simulations in drug discovery—from accelerating virtual screening to designing novel drug compounds and predicting protein structures. With advanced tools like AlphaFold and DiffDock, and platforms like Kwapio, biotech teams can now reduce costs, increase speed, and bring AI-native clarity to in silico testing. Powered by Pitchworks VC Studio, this shift is driving faster, smarter, and more scalable drug development.

This blog presents a strategic framework for evaluating Generative AI (GenAI) use cases in the Heavy Earth-Moving Vehicle (HEMV) sector. It categorizes opportunities into five clusters and introduces a score-based evaluation model validated by Pitchworks and Mr. Muralidharan Sudaram. With insights from Pitchworks GCC and GenAI Labs, it outlines how enterprises can drive structured AI adoption, enhance productivity, and scale innovation across industrial operations.